Skip to main content
Natera, Inc. logo

Natera, Inc. — Investor Relations & Filings

Ticker · NTRA ISIN · US6323071042 LEI · 529900CQ3OZ0A0VYVU59 US Human health and social work activities
Filings indexed 1,585 across all filing types
Latest filing 2018-05-08 Regulatory Filings
Country US United States of America
Listing US NTRA

About Natera, Inc.

https://www.natera.com/

Natera, Inc. is a diagnostics company specializing in cell-free DNA (cfDNA) testing. The company develops and commercializes non-invasive tests focused on three primary areas: women's health, oncology, and organ health. In women's health, its products include the Panorama non-invasive prenatal test (NIPT) and the Horizon carrier screening test to assess genetic risks. The oncology portfolio features Signatera, a personalized molecular residual disease (MRD) test used to monitor cancer recurrence and treatment response. For organ health, its tests are designed to detect early signs of transplant rejection. Natera's technology aims to provide actionable information for personalized medical care, supported by extensive clinical validation through numerous peer-reviewed studies.

Recent filings

Filing Released Lang Actions
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 8, 2018, reporting the results of operations and financial condition for the first quarter ended March 31, 2018. It references a press release and an investor presentation as exhibits. The document itself is relatively short (4155 characters) and primarily serves to announce the release of these materials rather than containing detailed financial statements or analysis. According to the 'Menu vs Meal' rule, such a document that announces or furnishes other reports but does not itself contain substantive financial data should be classified as a Regulatory Filing (RNS).
2018-05-08 English
4 Filing
Director's Dealing
2018-04-17 English
4 Filing
Director's Dealing
2018-04-17 English
4 Filing
Director's Dealing
2018-04-17 English
4 Filing
Director's Dealing
2018-04-13 English
DEF 14A Filing
Proxy Solicitation & Information Statement
2018-04-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.